LINE-1 methylation patterns of different loci in normal and cancerous cells.
This study evaluated methylation patterns of long interspersed nuclear element-1 (LINE-1) sequences from 17 loci in several cell types, including squamous cell cancer cell lines, normal oral epithelium (NOE), white blood cells and head and neck squamous cell cancers (HNSCC). Although sequences of each LINE-1 are homologous, LINE-1 methylation levels at each locus are different. Moreover, some loci demonstrate the different methylation levels between normal tissue types. Interestingly, in some chromosomal regions, wider ranges of LINE-1 methylation levels were observed. In cancerous cells, the methylation levels of most LINE-1 loci demonstrated a positive correlation with each other and with the genome-wide levels. Therefore, the loss of genome-wide methylation in cancerous cells occurs as a generalized process. However, different LINE-1 loci showed different incidences of HNSCC hypomethylation, which is a lower methylation level than NOE. Additionally, we report a closer direct association between two LINE-1s in different EPHA3 introns. Finally, hypermethylation of some LINE-1s can be found sporadically in cancer. In conclusion, even though the global hypomethylation process that occurs in cancerous cells can generally deplete LINE-1 methylation levels, LINE-1 methylation can be influenced differentially depending on where the particular sequences are located in the genome.
Phokaew
Chureerat
C
Inter-Department Program of BioMedical Sciences, Faculty of Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.
Kowudtitham
Supakit
S
Subbalekha
Keskanya
K
Shuangshoti
Shanop
S
Mutirangura
Apiwat
A
D045744:Cell Line, Tumor; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000378:metabolism; D006801:Humans; D020084:Long Interspersed Nucleotide Elements; D009369:Neoplasms / Q000235:genetics*; D016133:Polymerase Chain Reaction
D004273:DNA, Neoplasm
J Pathol. 2007 Feb;211(3):269-77
17139617
Gene. 2007 Apr 1;390(1-2):153-65
17141428
Cancer Genet Cytogenet. 1999 Feb;109(1):34-9
9973957
Int J Cancer. 2007 Oct 15;121(8):1724-8
17582607
Nucleic Acids Res. 1997 Jun 15;25(12):2532-4
9171110
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):108-14
17220338
Science. 2007 Feb 23;315(5815):1141-3
17322062
Lancet Oncol. 2008 Apr;9(4):359-66
18339581
Curr Top Microbiol Immunol. 2006;310:251-74
16909914
Oncogene. 2007 Apr 12;26(17):2518-24
17043645
Nat Genet. 1998 May;19(1):19-24
9590283
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8564-9
16361538
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):966-71
18398038
Cancer Metastasis Rev. 1999;18(1):65-73
10505546
Int J Gynecol Cancer. 2008 Jul-Aug;18(4):711-7
17944913
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Nat Rev Cancer. 2004 Feb;4(2):143-53
14732866
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2545-50
9122232
Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):307-9
17696752
PLoS One. 2007 May 02;2(5):e399
17476321
Biochem Cell Biol. 2005 Jun;83(3):296-321
15959557
Nucleic Acids Res. 2005 Dec 02;33(21):6823-36
16326863
Nat Genet. 1997 May;16(1):37-43
9140393
Oncogene. 2004 Nov 18;23(54):8841-6
15480421
Nature. 1999 Nov 11;402(6758):187-91
10647011
Clin Chim Acta. 2007 Apr;379(1-2):127-33
17303099
Int J Cancer. 1995 Mar 29;61(1):98-103
7705939
Nature. 1983 Jan 6;301(5895):89-92
6185846
J Biomed Biotechnol. 2006;2006(1):83672
16877821
Science. 2003 Apr 18;300(5618):455
12702868
Cancer Res. 1995 Oct 15;55(20):4525-30
7553621
Nature. 2001 Feb 15;409(6822):860-921
11237011
Nucleic Acids Res. 2008 Jun;36(11):3667-75
18474527